An Interview with Race in a Bottle author Jonathan Kahn
Earlier this week, we posted on BiDil, the first FDA-approved drug with a race-specific indication on its label. In the following interview with Columbia University Press, Jonathan Kahn, author of Race in a Bottle: The Story of BiDil and Racialized...